|
1
|
Fernandez-Gonzalez A, Alex MS, Liu X and
Kourembanas S: Vasculoprotective effects of hemeoxygenase-1 in a
murine model of hyperoxia-induced bronchopulmonary dysplasia. Am J
Physiol Lung Cell Mol Physiol. 302:L775–L784. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Merritt TA, Deming DD and Boynton BR: The
'new' bronchopulmonary dysplasia: Challenges and commentary. Semin
Fetal Neonatal Med. 14:345–357. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Joung KE, Kim HS, Lee J, Shim GH, Choi CW,
Kim EK, Kim BI and Choi JH: Correlation of urinary inflammatory and
oxidative stress markers in very low birth weight infants with
subsequent development of bronchopulmonary dysplasia. Free Radic
Res. 45:1024–1032. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gien J and Kinsella JP: Pathogenesis and
treatment of bronchopulmonary dysplasia. Curr Opin Pediatr.
23:305–313. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Köksal N, Kayik B, Çetinkaya M, Özkan H,
Budak F, Kiliç Ş, Canitez Y and Oral B: Value of serum and
bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine
levels for predicting bronchopulmonary dysplasia in premature
infants. Eur Cytokine Netw. 23:29–35. 2012.PubMed/NCBI
|
|
6
|
Samal B, Sun Y, Stearns G, Xie C, Suggs S
and McNiece I: Cloning and characterization of the cDNA encoding a
novel human pre-B-cell colony-enhancing factor. Mol Cell Biol.
14:1431–1437. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jia SH, Li Y, Parodo J, Kapus A, Fan L,
Rotstein OD and Marshall JC: Pre-B cell colony-enhancing factor
inhibits neutrophil apoptosis in experimental inflammation and
clinical sepsis. J Clin Invest. 113:1318–1327. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moschen AR, Kaser A, Enrich B, Mosheimer
B, Theurl M, Niederegger H and Tilg H: Visfatin, an adipocytokine
with proinflammatory and immunomodulating properties. J Immunol.
178:1748–1758. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ye SQ, Simon BA, Maloney JP,
Zambelli-Weiner A, Gao L, Grant A, Easley RB, McVerry BJ, Tuder RM,
Standiford T, et al: Pre-B-Cell colony-enhancing factor as a
potential novel biomarker in acute lung injury. Am J Resp Crit
Care. 171:361–370. 2005. View Article : Google Scholar
|
|
10
|
Li H, Liu P, Cepeda J, Fang D, Easley RB,
Simon BA, Zhang L and Ye S: Augmentation of pulmonary epithelial
cell IL-8 expression and permeability by pre-B-cell colony
enhancing factor. J Inflamm (Lond). 5:152008. View Article : Google Scholar :
|
|
11
|
Kim SR, Bae YH, Bae SK, Choi KS, Yoon KH,
Koo TH, Jang HO, Yun I, Kim KW, Kwon YG, et al: Visfatin enhances
ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation
in endothelial cells. Biochim Biophys Acta. 1783:886–895. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Otero M, Lago R, Gomez R, Lago F, Dieguez
C, Gomez-Reino JJ and Gualillo O: Changes in plasma levels of
fat-derived hormones adiponectin, leptin, resistin and visfatin in
patients with rheumatoid arthritis. Ann Rheum Dis. 65:1198–1201.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan Y, Meng S, Wang Y, Cao J and Wang C:
Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in
macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling
pathway. Int J Mol Med. 27:607–615. 2011.PubMed/NCBI
|
|
14
|
Edgell CJ, McDonald CC and Graham JB:
Permanent cell line expressing human factor VIII-related antigen
established by hybridization. Proc Natl Acad Sci USA. 80:3734–3737.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Edgell CJ, Haizlip JE, Bagnell CR,
Packenham JP, Harrison P, Wilbourn B and Madden VJ: Endothelium
specific Weibel-Palade bodies in a continuous human cell line,
EA.hy926. In Vitro Cell Dev Biol. 26:1167–1172. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu D, Perez RE, Ekekezie II, Navarro A and
Truog WE: Epidermal growth factor-like domain 7 protects
endothelial cells from hyperoxia-induced cell death. Am J Physiol
Lung Cell Mol Physiol. 294:L17–L23. 2008. View Article : Google Scholar
|
|
17
|
Thornhill MH, Li J and Haskard DO:
Leucocyte endothelial cell adhesion: A study comparing human
umbilical vein endothelial cells and the endothelial cell line
EA-hy-926. Scand J Immunol. 38:279–286. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song YH, Neumeister MW, Mowlavi A and
Suchy H: Tumor necrosis factor-alpha and lipopolysaccharides induce
differentially interleukin 8 and growth related oncogene-alpha
expression in human endothelial cell line EA.hy926. Ann Plast Surg.
45:681–683. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aranda E and Owen GI: A semi-quantitative
assay to screen for angiogenic compounds and compounds with
angiogenic potential using the EAhy926 endothelial cell line. Biol
Res. 42:377–389. 2009. View Article : Google Scholar
|
|
20
|
Cai W, Li Y, Yi Q, Xie F, Du B, Feng L and
Qiu L: Total saponins from Albizia julibrissin inhibit vascular
endothelial growth factor-mediated angiogenesis in vitro and in
vivo. Mol Med Rep. 11:3405–3413. 2015.PubMed/NCBI
|
|
21
|
Ye SQ, Zhang LQ, Adyshev D, Usatyuk PV,
Garcia AN, Lavoie TL, Verin AD, Natarajan V and Garcia JGN:
Pre-B-cell-colony-enhancing factor is critically involved in
thrombin-induced lung endothelial cell barrier dysregulation.
Microvasc Res. 70:142–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang WM, Liang YQ, Tang LJ, Ding Y and
Wang XH: Antioxidant and anti-inflammatory effects of Astragalus
polysaccharide on EA.hy926 cells. Exp Ther Med. 6:199–203.
2013.PubMed/NCBI
|
|
23
|
Wang X, Jia H, Deng L and Huang W:
Astragalus polysaccharides mediated preventive effects on
bronchopulmonary dysplasia in rats. Pediatr Res. 76:347–354. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bose CL, Dammann CE and Laughon MM:
Bronchopulmonary dysplasia and inflammatory biomarkers in the
premature neonate. Arch Dis Child Fetal Neonatal Ed. 93:F455–F461.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Speer CP: Chorioamnionitis, postnatal
factors and proinflammatory response in the pathogenetic sequence
of bronchopulmonary dysplasia. Neonatology. 95:353–361. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Robriquet L, Collet F, Tournoys A,
Prangère T, Nevière R, Fourrier F and Guery BP: Intravenous
administration of activated protein C in pseudomonas-induced lung
injury: Impact on lung fluid balance and the inflammatory response.
Respir Res. 7:412006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matsushima K1, Morishita K, Yoshimura T,
Lavu S, Kobayashi Y, Lew W, Appella E, Kung HF, Leonard EJ and
Oppenheim JJ: Molecular cloning of a human monocyte-derived
neutrophil chemotactic factor (MDNCF) and the induction of MDNCF
mRNA by interleukin 1 and tumor necrosis factor. J Exp Med.
167:1883–1893. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schraufstatter IU, Chung J and Burger M:
IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac
signaling pathways. Am J Physiol Lung Cell Mol Physiol.
280:L1094–L1103. 2001.PubMed/NCBI
|
|
29
|
Dunican AL, Leuenroth SJ, Grutkoski P,
Ayala A and Simms HH: TNFalpha-induced suppression of PMN apoptosis
is mediated through interleukin-8 production. Shock. 14:284–288.
288–289. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ognjanovic S and Bryant-Greenwood GD:
Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal
membranes. Am J Obstet Gynecol. 187:1051–1058. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sampath V, Garland JS, Helbling D, Dimmock
D, Mulrooney NP, Simpson PM, Murray JC and Dagle JM: Antioxidant
response genes sequence variants and BPD susceptibility in VLBW
infants. Pediatr Res. 77:477–483. 2015. View Article : Google Scholar
|
|
32
|
Jin L, Yang H, Fu J, Xue X, Yao L and Qiao
L: Association between oxidative DNA damage and the expression of
8-oxoguanine DNA glycosylase 1 in lung epithelial cells of neonatal
rats exposed to hyperoxia. Mol Med Rep. 11:4079–4086.
2015.PubMed/NCBI
|
|
33
|
Lum H and Roebuck KA: Oxidant stress and
endothelial cell dysfunction. Am J Physiol Cell Physiol.
280:C719–C741. 2001.PubMed/NCBI
|
|
34
|
Lee JW and Davis JM: Future applications
of antioxidants in premature infants. Curr Opin Pediatr.
23:161–166. 2011. View Article : Google Scholar
|
|
35
|
Martindale JL and Holbrook NJ: Cellular
response to oxidative stress: Signaling for suicide and survival. J
Cell Physiol. 192:1–15. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Welty SE: Is there a role for antioxidant
therapy in bronchopulmonary dysplasia? J Nutr. 131:947S–950S.
2001.PubMed/NCBI
|
|
37
|
Fortuno A, San JG, Moreno MU, Diez J and
Zalba G: Oxidative stress and vascular remodelling. Exp Physiol.
90:457–462. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang LQ, Adyshev DM, Singleton P, Li H,
Cepeda J, Huang SY, Zou X, Verin AD, Tu J, Garcia JGN, et al:
Interactions between PBEF and oxidative stress proteins - A
potential new mechanism underlying PBEF in the pathogenesis of
acute lung injury. FEBS Lett. 582:1802–1808. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kresch MJ, Christian C, Wu F and Hussain
N: Ontogeny of apoptosis during lung development. Pediatr Res.
43:426–431. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kroon AA, DelRiccio V, Tseu I, Kavanagh BP
and Post M: Mechanical ventilation-induced apoptosis in newborn rat
lung is mediated via FasL/Fas pathway. AJP Lung Cell Mol Physiol.
305:L795–L804. 2013. View Article : Google Scholar
|
|
41
|
Sherrill DL, Camilli A and Lebowitz MD: On
the temporal relationships between lung function and somatic
growth. Am Rev Respir Dis. 140:638–644. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Polunovsky VA, Chen B, Henke C, Snover D,
Wendt C, Ingbar DH and Bitterman PB: Role of mesenchymal cell death
in lung remodeling after injury. J Clin Invest. 92:388–397. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kazzaz JA, Xu J, Palaia TA, Mantell L,
Fein AM and Horowitz S: Cellular oxygen toxicity. Oxidant injury
without apoptosis. J Biol Chem. 271:15182–15186. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liener UC, Bruckner UB, Knoferl MW,
Steinbach G, Kinzl L and Gebhard F: Chemokine activation within 24
hours after blunt accident trauma. Shock. 17:169–172. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
May M, Strobel P, Preisshofen T,
Seidenspinner S, Marx A and Speer CP: Apoptosis and proliferation
in lungs of ventilated and oxygen-treated preterm infants. Eur
Respir J. 23:113–121. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gao W, Mao Q, Feng A, Sun HM, Sun WK, Lu
X, Su X and Shi Y: Inhibition of pre-B cell colony-enhancing factor
attenuates inflammation and apoptosis induced by pandemic H1N1 2009
in lung endothelium. Respir Physiol Neurobiol. 178:235–241. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ming GF, Ma XH, Xu DM, Liu ZY, Ai YH, Liu
HX and Shi ZH: PBEF promotes the apoptosis of pulmonary
microvascular endothelial cells and regulates the expression of
inflammatory factors and AQP1 through the MAPK pathways. Int J Mol
Med. 36:890–896. 2015.PubMed/NCBI
|
